Facebook
Twitter
Telegram
Fehler meldenCoherus BioSciences Bilanz 2011-2024 | CHRS
Bilanz Jährlich Coherus BioSciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-101 M | -59 M | -414 M | -135 M | 11 M | 30.7 M | -25.1 M | -23.8 M | -158 M | -150 M | -35.4 M | -12.8 M | - |
Langfristige Schulden |
351 K | 1.42 M | 498 K | 404 M | 178 M | 103 M | 102 M | 100 M | - | - | - | - | - |
Langfristiger Schuldenstrom |
1.42 M | 3.13 M | 2.75 M | 2.57 M | 2.2 M | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 189 M | 105 M | 104 M | 103 M | 113 M | 68.7 M | 36.1 M | 6.09 M | - |
Kurzfristige Verbindlichkeiten |
332 M | 139 M | 165 M | 146 M | 115 M | 33.3 M | 28.4 M | 56.4 M | 106 M | 51.8 M | - | - | - |
Gesamtverbindlichkeiten |
823 M | 618 M | 582 M | 561 M | 304 M | 138 M | 132 M | 159 M | 219 M | 120 M | 89.8 M | 17.3 M | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | 1.96 M | 51 M | 24 M | 14.3 M | 2.02 M | - |
Gewinnrücklagen |
-1.58 B | -1.34 B | -1.05 B | -763 M | -895 M | -985 M | -775 M | -537 M | -410 M | -187 M | -99.6 M | -46 M | - |
Vermögenswerte |
630 M | 481 M | 679 M | 842 M | 409 M | 99.5 M | 163 M | 178 M | 212 M | 187 M | 47.4 M | 26.5 M | - |
Zahlungsmittel |
103 M | 63.5 M | 417 M | 541 M | 178 M | 72.4 M | 127 M | 125 M | 158 M | 150 M | 39.6 M | 14.5 M | - |
Buchwert |
-193 M | -137 M | 97.7 M | 281 M | 105 M | -38.6 M | 30.5 M | 19.4 M | -6.93 M | 66.8 M | -42.4 M | 9.19 M | - |
Gesamtes Eigenkapital |
-193 M | -137 M | 97.7 M | 281 M | 105 M | -38.6 M | 31.8 M | 20.5 M | -6.21 M | 66.8 M | -97.1 M | -45.5 M | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Coherus BioSciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | - | - | - | - | - | - | - | 498 K | - | - | 869 K | 875 K | 986 K | 952 K | 875 K | 73.7 M | 10.3 M | 73.3 M | 73.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
845 M | 823 M | 717 M | 644 M | 599 M | 618 M | 648 M | - | 581 M | 582 M | 611 M | 583 M | 566 M | 561 M | 561 M | 561 M | 561 M | 304 M | 304 M | 304 M | 304 M | 138 M | 138 M | 138 M | 138 M | 132 M | 132 M | 132 M | 132 M | 159 M | 159 M | 159 M | 159 M | 219 M | 219 M | 219 M | 219 M | 120 M | 120 M | 120 M | 120 M | 89.8 M | 89.8 M | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 669 K | 892 K | 892 K | 892 K | 892 K | 49.6 M | 49.6 M | 49.6 M | 49.6 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | 14.3 M | 14.3 M | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-1.48 B | -1.58 B | -1.5 B | -1.46 B | -1.42 B | -1.34 B | -1.28 B | - | -1.15 B | -1.05 B | -1 B | -966 M | -936 M | -763 M | -763 M | -763 M | -763 M | -895 M | -895 M | -895 M | -895 M | -985 M | -985 M | -985 M | -985 M | -775 M | -775 M | -775 M | -775 M | -537 M | -537 M | -537 M | -537 M | -410 M | -410 M | -410 M | -410 M | -187 M | -187 M | -187 M | -187 M | -99.6 M | -99.6 M | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
764 M | 630 M | 584 M | 470 M | 402 M | 481 M | 551 M | - | 593 M | 679 M | 742 M | 740 M | 693 M | 842 M | 842 M | 842 M | 842 M | 409 M | 409 M | 409 M | 409 M | 99.5 M | 99.5 M | 99.5 M | 99.5 M | 163 M | 163 M | 163 M | 163 M | 178 M | 178 M | 178 M | 178 M | 212 M | 212 M | 212 M | 212 M | 187 M | 187 M | 187 M | 187 M | 47.4 M | 47.4 M | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
260 M | 103 M | 80.3 M | 72.9 M | 16.1 M | 63.5 M | 287 M | 275 M | 326 M | 417 M | 361 M | 330 M | 259 M | 541 M | 541 M | 541 M | 541 M | 178 M | 178 M | 178 M | 178 M | 72.4 M | 72.4 M | 72.4 M | 72.4 M | 127 M | 127 M | 127 M | 127 M | 125 M | 125 M | 125 M | 125 M | 158 M | 158 M | 158 M | 158 M | 150 M | 150 M | 150 M | 150 M | 39.6 M | 39.6 M | - | - | 14.5 M | - | - | - | 7.68 M | - | - | - |
Buchwert |
-81.8 M | -193 M | -134 M | -175 M | -197 M | -137 M | -97.1 M | - | 12.6 M | 97.7 M | 131 M | 156 M | 128 M | 281 M | 281 M | 281 M | 281 M | 105 M | 105 M | 105 M | 105 M | -38.6 M | -38.6 M | -38.6 M | -38.6 M | 30.5 M | 30.5 M | 30.5 M | 30.5 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | -6.93 M | -6.93 M | -6.93 M | -6.93 M | 66.8 M | 66.8 M | 66.8 M | 66.8 M | -42.4 M | -42.4 M | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
-81.8 M | -193 M | -134 M | -175 M | -197 M | -137 M | -97.1 M | -22.6 M | 12.6 M | 97.7 M | 131 M | 156 M | 128 M | 281 M | 281 M | 281 M | 281 M | 105 M | 105 M | 105 M | 105 M | -38.6 M | 12.4 M | 63.2 M | -1.79 M | 30.5 M | 31.8 M | 31.8 M | 31.8 M | 20.5 M | 20.5 M | 20.5 M | 20.5 M | -6.21 M | -6.21 M | -6.21 M | -6.21 M | 66.8 M | 66.8 M | 66.8 M | 66.8 M | -97.1 M | -97.1 M | - | - | -45.5 M | - | - | - | -2.31 M | - | - | - |
Alle Zahlen in USD-Währung